Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
2. Translating Antiviral Therapies to Veterinary Use: A Review of Immunomodulatory Agents for Potential Application in Aleutian Mink Diseases
- Kondracki M. , et al.
3. Research Progress in Adverse Reactions Caused by Obinutuzumab in the Treatment of Follicular Lymphoma
- Zhong X. , et al.
4. Impact of Hepatitis B Infection on Patient and Graft Survival After Kidney Transplantation
- Paschereit A. , et al.
5. Risk of HBV reactivation in psoriasis vulgaris patients receiving biological agent therapy
- Kankılıç A.T. , et al.
7. Immune response to occult hepatitis B virus infection among hemodialysis patients: A review
- Mussa A. , et al.
8. Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens
- Lu R. , et al.
9. SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection
- Shoraka S. , et al.
10. Adoptive immune transfer from donors offers Anti-HBV protection to HBsAb-negative patients after Allo-HSCT
- Ren J. , et al.
12. Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19
- Sagnelli C. , et al.
13. Determination of reactivation rate and risk factors for Hepatitis B virus reactivation in low-positive cases: A retrospective cohort study
- Yonezawa H. , et al.
14. Frequency of Hepatitis B Virus infection among Patients before Chemotherapy Treatment
- Mahmoudvand S. , et al.
15. Immune phase transition under steroid treatment
- Nayak S.P. , et al.
16. A practical algorithm for non-hepatologists to prevent hepatitis B reactivation related to immunosuppressive treatment and chemotherapy
- Ulasoglu C. , et al.
17. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival
- Qin S.K. , et al.
18. The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence
- Tapia Rico G. , et al.
19. Iranian guideline for rituximab therapy in pemphigus patients
- Daneshpazhooh M. , et al.
20. Hepatitis B Reactivation Rate Is Higher Undergoing Some Cytotoxic Chemotherapy in Patients with Solid Tumors: A Large Retrospective Study
- Karaca M. , et al.
21. Tenofovir alafenamide: A new drug with various ambiguous aspects in treatment of chronic hepatitis b infection
- Tavakolpour S. , et al.
22. Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy
- Kusumoto S. , et al.
23. Hepatitis B virus reactivation in patients with hematological malignancies under lamivudine prophylaxis
- Iskender G. , et al.
24. Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections
- Hilal T. , et al.
25. Management of chronic viral hepatitis in the hematological patient
- Nicolini L.A. , et al.